Samuel Whiting

Chief Medical Officer, Tempest Therapeutics, Inc.

Companies

Tempest Therapeutics, Inc.Chief Medical Officer Jun 30, 2021 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Tempest Therapeutics, Inc. TPST9,573 shares²$6.1K at $0.63Jul 2, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 2, 2024Bought 4,672 shares at $2.13 of Tempest Therapeutics, Inc.²
Jan 6, 2022Bought 1,700 shares at $4.80 of Tempest Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTempest Therapeutics, Inc., Chief Medical Officer
2
SEC EDGARTempest Therapeutics, Inc. shares after the filing of Jul 2, 2024
3
SEC EDGARForm 4 filed Jan 10, 2022